Battalion Oil Corp  (HK)
Other Ticker:  
    Sector  Energy    Industry Oil And Gas Production
   Industry Oil And Gas Production
   Sector  Energy
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 16
 Employees 245
 Revenues (TTM) (Millions $) 148
 Net Income (TTM) (Millions $) -230
 Cash Flow (TTM) (Millions $) -19
 Capital Exp. (TTM) (Millions $) 43

Battalion Oil Corp
We are an independent energy company focused on the acquisition, production, exploration and development of onshore liquids-rich oil and natural gas assets in the United States. We were incorporated in Delaware on February 5, 2004, recapitalized on February 8, 2012 and reorganized on September 9, 2016. During 2012, we focused our efforts on the acquisition of unevaluated leasehold and producing properties in select prospect areas. In the years since, we have primarily focused on the development of acquired properties and also divested non-core assets in order to fund activities in our core resource plays. Our oil and natural gas assets consist of proved reserves and undeveloped acreage positions in unconventional liquids-rich basins/fields, providing us with an extensive drilling inventory in multiple basins that we believe allow for multiple years of production and broad flexibility to direct our capital resources to projects with the greatest potential returns. As discussed below in more detail under "Recent Developments," we have recently acquired certain properties in the Southern Delaware Basin for $705.0 million and entered into an agreement to sell our assets located in the El Halcón area of East Texas for $500.0 million, which is expected to close by early March 2017.

   HK is expected to report next financial results on August 03, 2021.

Customers recorded net loss Customers recorded net loss

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
APA        7.95% 
PARR   -3.69%    
OXY        8% 
OKE        1.99% 
MRO        5.6% 
EOG        12.85% 
• View Complete Report

Enpro Industries Inc

Results more than Doubled

Enpro Industries Inc has more than doubled its results in the financial period ending Mar 31 2021 compared to same quarter a year ago, earnings per share soared by 545.75 % to $0.87 and Sales soared by 227.05% to $279.30 millions.

compared to previous quarter EPS turn positive from $-0.96 per share and Sales increased by 4.1 % from $268.30 millions.

Anika Therapeutics Inc

A $1.62 million tax benefit, helped Anika Therapeutics Inc to post $0.20 eps in the first quarter of 2021 earnings season

A $1.62 million tax benefit, helped Anika Therapeutics Inc to post $0.20 eps in the first quarter of 2021 earnings season

Sales contracted by -3.12% to $34.29 millions from $35.40 millions in the same quarter a year ago and sequentially Sales increased by 4.91 % from $32.69 millions.

Ufp Technologies Inc

Ufp Technologies Inc announced fiscal time frame ending Mar 31 2021 operating surplus of $5.3 millions

Ufp Technologies Inc reported moderate Sales growth of 0.67% to $48.60 millions in the fiscal time frame ending Mar 31 2021, income increased by 5.77 % to $0.55 year on year.

Sales advanced by 7.63 % from $45.15 millions in preceding period, income income improved by 0.81 % from $0.55 per share.

Biocryst Pharmaceuticals Inc

Losses Widen, Topline Tumbles

Biocryst Pharmaceuticals Inc reported disastrous first quarter of 2021, where Sales faded by -52.02% to $19.06 millions and loss per share has widen to $-0.36, from the same quarter a year ago.

Income improved from the preceding quarter from $-0.26 per share, Sales doubled by 212.34 % from $6.10 millions.

Harvard Bioscience Inc

Despite Strong Sales Profitability not Reached

Although company's Sales increased by 13.54% from the same quarter a year ago to $26.99 millions in the fiscal first quarter of 2021, Harvard Bioscience Inc lost money at $-0.02 loss per share.

Looking into results from previous quarter Sales deteriorated by -12.89% from $30.98 millions and from $-0.02 per share.


Battalion Oil's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

OBNK's Profile

Stock Price

OBNK's Financials

Business Description


Charts & Quotes

OBNK's News


OBNK's Competitors

Customers & Markets

Economic Indicators

OBNK's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071